Loring Wolcott & Coolidge Fiduciary Advisors LLP Organon & Co. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Organon & Co. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,760 shares of OGN stock, worth $32,190. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,760
Previous 1,748
0.69%
Holding current value
$32,190
Previous $32,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OGN
# of Institutions
794Shares Held
191MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$596 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$553 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$185 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$165 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$136 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.65B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...